Hart Expresses Concern Over Value Assessments in Coverage Decisions

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2W2zLeT on October 20, 2019 at 07:49PM BioNJ President and CEO Debbie Hart in a recent column published on NJ Spotlight describes the rising interest in using value assessments in health policies’ coverage decisions as a “troubling” development. Hart takes aim at the Institute for Clinical and Economic […]

Does genetics matter for disease-related stigma? The impact of genetic attribution on stigma associated with rheumatic heart disease in the Western Cape, South Africa

from Social Science & Medicine at http://bit.ly/31yUecm on October 20, 2019 at 03:16PM Publication date: Available online 19 October 2019 Source: Social Science & Medicine Author(s): Marlyn Faure, Olivia Matshabane, Patricia Marshall, Paul S. Appelbaum, Dan J. Stein, Mark E. Engel, Jantina de Vries Abstract Introduction A common concern in African genomic research is that […]

Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review

from Health Policy at http://bit.ly/35TPuSi on October 20, 2019 at 03:01PM Publication date: Available online 19 October 2019 Source: Health Policy Author(s): ACC Beck, VP Retèl, PA Bhairosing, MWM van den Brekel, WH van Harten ABSTRACT A large number of medical devices (MDs) is available in Europe. Procedures for market approval and reimbursement have been […]